Related Experiment Video

Updated: Apr 18, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.9K

RBPJ inhibition impairs the growth of lung cancer

Qun Lv1, Ronglin Shen, Jianjun Wang

  • 1Department of Pulmonary Medicine, The Affiliated Hospital of Hangzhou Normal University, 126 Wenzhou Road, 310015, Hangzhou, China.

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|January 16, 2015
PubMed

Insights

Inhibiting Recombination signal-binding protein Jκ (RBPJ) using short hairpin interfering RNA (shRNA) significantly reduced lung cancer cell growth. This targeted approach modulated key downstream genes, offering a potential new therapy for lung cancer.

Area of Science:

  • Molecular biology
  • Cancer research
  • Cell signaling

Background:

  • Notch signaling pathway's effect on cell growth varies by tumor type.
  • Recombination signal-binding protein Jκ (RBPJ) is a critical transcription factor in Notch signaling.

Purpose of the Study:

  • To investigate the impact of RBPJ inhibition on lung cancer cell proliferation.
  • To explore RBPJ as a therapeutic target in lung cancer.

Main Methods:

  • Utilized short hairpin interfering RNA (shRNA) to inhibit RBPJ expression in lung cancer cells.
  • Analyzed changes in downstream target gene expression (p21, p27, CDK2, Hes1, Bcl-2, SKP2).

Main Results:

  • shRNA effectively suppressed RBPJ expression in lung cancer cells.
  • RBPJ inhibition led to a significant decrease in lung cancer cell growth.
  • Expression levels of key cell cycle and apoptosis regulators were altered by RBPJ inhibition.

Conclusions:

  • Targeted inhibition of RBPJ via shRNA demonstrates anti-proliferative effects on lung cancer cells.
  • RBPJ is a viable therapeutic target for human lung cancer treatment.
  • Modulation of RBPJ downstream targets plays a crucial role in its anti-cancer effects.

More Related Videos

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues07:39

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

10.0K
Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.9K

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
5.0K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.7K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K